Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
Violeta Kourbeli, Eleni Chontzopoulou, Kalliopi Moschovou, et al.
Molecules (2021) Vol. 26, Iss. 15, pp. 4629-4629
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Synthesis, characterization, DFT studies, and molecular modeling of azo dye derivatives as potential candidate for trypanosomiasis treatment
Ernest C. Agwamba, Akaninyene D. Udoikono, Hitler Louis, et al.
Chemical Physics Impact (2022) Vol. 4, pp. 100076-100076
Open Access | Times Cited: 71
An Update on African Trypanocide Pharmaceutics and Resistance
Keneth Iceland Kasozi, Ewan T. MacLeod, Ibrahim Ntulume, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 55
Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases
Simone Brogi, Roberta Ibba, Sara Rossi, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2561-2561
Open Access | Times Cited: 29
State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation
Juan Carlos Gabaldón-Figueira, Nieves Martínez-Peinado, Elisa Escabia, et al.
Research and Reports in Tropical Medicine (2023) Vol. Volume 14, pp. 1-19
Open Access | Times Cited: 17
Facing diseases caused by trypanosomatid parasites: rational design of multifunctional oxidovanadium(IV) complexes with bioactive ligands
Gonzalo Scalese, Ignacio Machado, Fabiana Salazar, et al.
Frontiers in Chemical Biology (2024) Vol. 2
Open Access | Times Cited: 4
The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
Hayelom Berhe Dagnaw, Mahesh Kumar Cinthakunta Sridhar, Mulate Zerihun, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 227-227
Open Access | Times Cited: 4
Targeting Trypanothione Metabolism in Trypanosomatids
María-Cristina González-Montero, Julia Andrés-Rodríguez, Nerea García-Fernández, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2214-2214
Open Access | Times Cited: 4
Polyamine Metabolism for Drug Intervention in Trypanosomatids
Yolanda Pérez‐Pertejo, Carlos García‐Estrada, María Martínez Valladares, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 79-79
Open Access | Times Cited: 3
Facing Diseases Caused by Trypanosomatid Parasites: Rational Design of Pd and Pt Complexes With Bioactive Ligands
Dinorah Gambino, Lucı́a Otero
Frontiers in Chemistry (2022) Vol. 9
Open Access | Times Cited: 18
Antimicrobial Peptides (AMPs): Potential Therapeutic Strategy against Trypanosomiases?
Maura Rojas-Pirela, Ulrike Kemmerling, Wilfredo Quiñones, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 599-599
Open Access | Times Cited: 10
Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases
Andreina Henriquez-Figuereo, Cristina Morán-Serradilla, Eduardo Angulo-Elizari, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 115002-115002
Open Access | Times Cited: 16
Metallomics and other omics approaches in antiparasitic metal-based drug research
Gonzalo Scalese, Kateryna Kostenkova, Debbie C. Crans, et al.
Current Opinion in Chemical Biology (2022) Vol. 67, pp. 102127-102127
Closed Access | Times Cited: 15
Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases
Igor José dos Santos Nascimento, Misael de Azevedo Teotônio Cavalcanti, Ricardo Olímpio de Moura
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115550-115550
Closed Access | Times Cited: 9
1,3-Thiazole derivatives as privileged structures for anti-Trypanosoma cruzi activity: Rational design, synthesis, in silico and in vitro studies
Mabilly Cox Holanda de Barros Dias, Mayara Souza Barbalho, Gevânio Bezerra de Oliveira Filho, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115508-115508
Closed Access | Times Cited: 8
Insights of potential trypanocidal effect of the synthetic derivative (2E)-1-(4-aminophenyl)-3-(2,4-dichlorophenyl)prop-2-en-1-one: in vitro assay, MEV analysis, quantum study, molecular docking, molecular dynamics, MPO analysis, and predictive ADMET
Márcia Machado Marinho, Matheus Nunes da Rocha, Emanuel Paula Magalhães, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7797-7818
Closed Access | Times Cited: 2
The Oxidative Stress and Chronic Inflammatory Process in Chagas Disease: Role of Exosomes and Contributing Genetic Factors
Edio Maldonado, Diego Rojas, Fabiola Urbina, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 21
Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?
Miguel Marín, M. Allué López, Laura Gallego‐Yerga, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1055-1120
Open Access | Times Cited: 6
Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas’ Disease
Marta L. Lima, L.B. Tulloch, Victoriano Corpas‐López, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 66, Iss. 1
Open Access | Times Cited: 16
Vaccine Design against Chagas Disease Focused on the Use of Nucleic Acids
Edio Maldonado, Sebastián Morales, Fabiola Urbina, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 587-587
Open Access | Times Cited: 11
New multifunctional Ru(II) organometallic compounds show activity against Trypanosoma brucei and Leishmania infantum
Feriannys Rivas, Carolina Del Mármol, Gonzalo Scalese, et al.
Journal of Inorganic Biochemistry (2022) Vol. 237, pp. 112016-112016
Closed Access | Times Cited: 11
Unique thiol metabolism in trypanosomatids: Redox homeostasis and drug resistance
Vahab Ali, Sachidananda Behera, Afreen Nawaz, et al.
Advances in Parasitology/Advances in parasitology (2022), pp. 75-155
Closed Access | Times Cited: 9
An In vitro and in silico investigation of the antitrypanosomal activities of the stem bark extracts of Anopyxis klaineana (Pierre) Engl
Latif Adams, Dorcas Obiri-Yeboah, Michael Afiadenyo, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28025-e28025
Open Access | Times Cited: 1
Designing Antitrypanosomal and Antileishmanial BODIPY Derivatives: A Computational and In Vitro Assessment
Raquel C. R. Gonçalves, Filipe Teixeira, Pablo Peñalver, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2072-2072
Open Access | Times Cited: 1
Multifunctional Organometallic Compounds Active against Infective Trypanosomes: Ru(II) Ferrocenyl Derivatives with Two Different Bioactive Ligands
Feriannys Rivas, Carolina Del Mármol, Gonzalo Scalese, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 25, pp. 11667-11687
Closed Access | Times Cited: 1
1,2,4-Oxadiazole Derivatives: Physicochemical Properties, Antileishmanial Potential, Docking and Molecular Dynamic Simulations of Leishmania infantum Target Proteins
Deyzi Caroline da Silva Barbosa, Vanderlan Nogueira Holanda, Elton Marlon de Araújo Lima, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4654-4654
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top